<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37558268</PMID><DateCompleted><Year>2023</Year><Month>08</Month><Day>11</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>12</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">2053-8790</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><Issue>2</Issue><PubDate><Year>2023</Year><Month>Aug</Month></PubDate></JournalIssue><Title>Lupus science &amp; medicine</Title><ISOAbbreviation>Lupus Sci Med</ISOAbbreviation></Journal><ArticleTitle>Vitamin D level in patients with systemic lupus erythematosus: its relationship to disease course and bone mineral density.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e000968</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1136/lupus-2023-000968</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To determine vitamin D levels in patients with SLE and evaluate their relationship to bone mineral density (BMD) and the disease course.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">The study included 101 patients with SLE and 29 individuals in the control group. The study participants were tested for vitamin D level, erythrocyte sedimentation rate (ESR), C reactive protein (CRP), interleukin (IL)-6, osteocalcin (OC) and collagen type I C-terminal telopeptide (CTX), and the dual-energy X-ray absorptiometry was provided to assess BMD in the lumbar spine and the hip.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The mean serum vitamin D level was 18.98&#xb1;0.88 ng/mL, and women had 25.42% lower vitamin D levels than men (p&lt;0.05). There was no correlation between vitamin D levels and patient's age or disease course. There was a significant inverse correlation between vitamin D levels and cumulative dose of glucocorticoids (r=-0.26) and serum inflammatory markers, particularly CRP (r=-0.39), IL-6 (r=-0.37) and ESR (r=-0.15). Vitamin D level was associated with the bone turnover markers (BTMs). In women of reproductive age with vitamin D deficiency, BMD of the lumbar spine and the hip was 9.5-23.1% higher than in those with no vitamin deficiency, respectively, and the mean lumbar spine Z-score in women of reproductive age with vitamin D insufficiency and deficiency was significantly 2.0 and 2.9 times lower than in patients with normal vitamin D level.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Hypovitaminosis D is quite common in patients with SLE and is associated with high inflammatory activity (SLE Disease Activity Index, ESR, CRP, IL-6), severity of organ damage (Damage Index), cumulative dose of glucocorticoids, BTM changes (decrease in OC, increase in CTX) and BMD decline. Vitamin D status was not associated with the patient's age or disease course.</AbstractText><CopyrightInformation>&#xa9; Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shevchuk</LastName><ForeName>Sergii</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-5649-2775</Identifier><AffiliationInfo><Affiliation>Vinnytsia National Medical University, Vinnytsia, Ukraine.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Research Institute for Rehabilitation of Individuals with Disabilities (Educational and Scientific Treatment Facility) of Vinnytsia National Medical University, Vinnytsia, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marynych</LastName><ForeName>Liubov</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2191-3477</Identifier><AffiliationInfo><Affiliation>Vinnytsia National Medical University, Vinnytsia, Ukraine lyuba27@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Malovana</LastName><ForeName>Tetiana</ForeName><Initials>T</Initials><Identifier Source="ORCID">0009-0003-8210-4072</Identifier><AffiliationInfo><Affiliation>Vinnytsia National Medical University, Vinnytsia, Ukraine.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Denyshchych</LastName><ForeName>Liudmyla</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-9366-8648</Identifier><AffiliationInfo><Affiliation>Vinnytsia National Medical University, Vinnytsia, Ukraine.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus Sci Med</MedlineTA><NlmUniqueID>101633705</NlmUniqueID><ISSNLinking>2053-8790</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D005938">Glucocorticoids</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015850">Interleukin-6</NameOfSubstance></Chemical><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015519" MajorTopicYN="Y">Bone Density</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005938" MajorTopicYN="N">Glucocorticoids</DescriptorName><QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015850" MajorTopicYN="N">Interleukin-6</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bone Mineral Density</Keyword><Keyword MajorTopicYN="N">Disease Activity</Keyword><Keyword MajorTopicYN="N">Glucocorticoids</Keyword><Keyword MajorTopicYN="N">Lupus Erythematosus, Systemic</Keyword><Keyword MajorTopicYN="N">Osteoporosis</Keyword></KeywordList><CoiStatement>Competing interests: None declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>7</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>8</Month><Day>11</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>8</Month><Day>10</Day><Hour>0</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>8</Month><Day>9</Day><Hour>20</Hour><Minute>52</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37558268</ArticleId><ArticleId IdType="pmc">PMC10414063</ArticleId><ArticleId IdType="doi">10.1136/lupus-2023-000968</ArticleId><ArticleId IdType="pii">10/2/e000968</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Magro R, Saliba C, Camilleri L, et al. . Vitamin D supplementation in systemic lupus erythematosus: relationship to disease activity, fatigue and the interferon signature gene expression. BMC Rheumatol 2021;5:53. 10.1186/s41927-021-00223-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s41927-021-00223-1</ArticleId><ArticleId IdType="pmc">PMC8641172</ArticleId><ArticleId IdType="pubmed">34857051</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams JS, Hewison M. Unexpected actions of vitamin D: new perspectives on the regulation of innate and adaptive immunity. Nat Clin Pract Endocrinol Metab 2008;4:80&#x2013;90. 10.1038/ncpendmet0716</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncpendmet0716</ArticleId><ArticleId IdType="pmc">PMC2678245</ArticleId><ArticleId IdType="pubmed">18212810</ArticleId></ArticleIdList></Reference><Reference><Citation>Szymczak I, Pawliczak R. The active metabolite of vitamin D3 as a potential Immunomodulator. Scand J Immunol 2016;83:83&#x2013;91. 10.1111/sji.12403</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sji.12403</ArticleId><ArticleId IdType="pubmed">26678915</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima GL, Paupitz J, Aikawa NE, et al. . Vitamin D supplementation in adolescents and young adults with juvenile systemic lupus erythematosus for improvement in disease activity and fatigue scores: a randomized. Arthritis Care Res (Hoboken) 2016;68:91&#x2013;8. 10.1002/acr.22621</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22621</ArticleId><ArticleId IdType="pubmed">25988278</ArticleId></ArticleIdList></Reference><Reference><Citation>Rifa&#x2019;i A, Kalim H, Kusworini K, et al. . Effect of vitamin D supplementation on disease activity (SLEDAI) and fatigue in systemic lupus erythematosus patients with Hipovitamin D: an open clinical trial. Ina J Rheum 2018;8. 10.37275/ijr.v8i2.59</Citation><ArticleIdList><ArticleId IdType="doi">10.37275/ijr.v8i2.59</ArticleId></ArticleIdList></Reference><Reference><Citation>Karimzadeh H, Shirzadi M, Karimifar M. The effect of vitamin D supplementation in disease activity of systemic lupus erythematosus patients with vitamin D deficiency: a randomized clinical trial. J Res Med Sci 2017;22:4. 10.4103/1735-1995.199089</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/1735-1995.199089</ArticleId><ArticleId IdType="pmc">PMC5361443</ArticleId><ArticleId IdType="pubmed">28400826</ArticleId></ArticleIdList></Reference><Reference><Citation>Singgih Wahono C, Diah Setyorini C, Kalim H, et al. . Effect of Curcuma Xanthorrhiza supplementation on systemic lupus erythematosus patients with Hypovitamin D which were given vitamin D3 towards disease activity (SLEDAI), IL-6, and TGF-&#x392;1 serum. Int J Rheumatol 2017;2017:7687053. 10.1155/2017/7687053</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/7687053</ArticleId><ArticleId IdType="pmc">PMC5763117</ArticleId><ArticleId IdType="pubmed">29445400</ArticleId></ArticleIdList></Reference><Reference><Citation>Pakchotanon R, Lomarat W, Narongroeknawin P, et al. . Randomized double-blind controlled trial to evaluate efficacy of vitamin D supplementation among patients with systemic lupus erythematosus. J Southeast Asian Med Res 2020;4:24&#x2013;32. 10.55374/jseamed.v4i1.57</Citation><ArticleIdList><ArticleId IdType="doi">10.55374/jseamed.v4i1.57</ArticleId></ArticleIdList></Reference><Reference><Citation>Dall&#x2019;Ara F, Andreoli L, Piva N, et al. . Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patients. Clin Exp Rheumatol 2015;33:153&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">25664429</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoffecker BM, Raffield LM, Kamen DL, et al. . Systemic lupus erythematosus and vitamin D deficiency are associated Wit&#x430;h shorter telomere length among African Americans. PLoS One 2013;8:e63725. 10.1371/journal.pone.0063725</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0063725</ArticleId><ArticleId IdType="pmc">PMC3658981</ArticleId><ArticleId IdType="pubmed">23700431</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal M, Tripathy R, Panda AK, et al. . Vitamin D levels in Indian systemic lupus erythematosus patients: association with disease activity index and interferon alpha. Arthritis Res Ther 2014;16:R49. 10.1186/ar4479</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar4479</ArticleId><ArticleId IdType="pmc">PMC3979045</ArticleId><ArticleId IdType="pubmed">24507879</ArticleId></ArticleIdList></Reference><Reference><Citation>Schoindre Y, Jallouli M, Tanguy M-L, et al. . Lower vitamin D levels are associated with higher systemic lupus erythematosus activity, but not predictive of disease flare-up. Lupus Sci Med 2014;1:e000027. 10.1136/lupus-2014-000027</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000027</ArticleId><ArticleId IdType="pmc">PMC4213833</ArticleId><ArticleId IdType="pubmed">25379192</ArticleId></ArticleIdList></Reference><Reference><Citation>Yap KS, Northcott M, Hoi ABY, et al. . Association of low vitamin D with high disease activity in an Australian systemic lupus erythematosus cohort. Lupus Sci Med 2015;2:e000064. 10.1136/lupus-2014-000064</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2014-000064</ArticleId><ArticleId IdType="pmc">PMC4395813</ArticleId><ArticleId IdType="pubmed">25893106</ArticleId></ArticleIdList></Reference><Reference><Citation>Ding Y, Liao W, He XJ, et al. . Effects of 1,25(OH)2D3 and vitamin D receptor on peripheral CD4+/CD8+ double-positive T lymphocytes in a mouse model of systemic lupus erythematosus. J Cell Mol Med 2017;21:975&#x2013;85. 10.1111/jcmm.13037</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jcmm.13037</ArticleId><ArticleId IdType="pmc">PMC5387123</ArticleId><ArticleId IdType="pubmed">28063200</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez Sep&#xfa;lveda JI, Bolin K, Mofors J, et al. . Sex differences in clinical presentation of systemic lupus erythematosus. Biol Sex Differ 2019;10:60. 10.1186/s13293-019-0274-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13293-019-0274-2</ArticleId><ArticleId IdType="pmc">PMC6915972</ArticleId><ArticleId IdType="pubmed">31843005</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Irastorza G, Egurbide MV, Olivares N, et al. . Vitamin D deficiency in systemic lupus erythematosus: prevalence, predictors and clinical consequences. Rheumatology (Oxford) 2008;47:920&#x2013;3. 10.1093/rheumatology/ken121</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/ken121</ArticleId><ArticleId IdType="pubmed">18411213</ArticleId></ArticleIdList></Reference><Reference><Citation>Abdel Galil SM, El-Shafey AM, Abdul-Maksoud RS, et al. . Interferon alpha gene expression and serum level association with low vitamin D levels in Egyptian female patients with systemic lupus erythematosus. Lupus 2018;27:199&#x2013;209. 10.1177/0961203317716321</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203317716321</ArticleId><ArticleId IdType="pubmed">28659049</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x415;loi M, Horvath DV, Ortega JC, et al. . Is associated with disease activity in systemic lupus erythematosus patients. PLoS One 2017;12:e0170323. 10.1371/journal.pone.0170323</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0170323</ArticleId><ArticleId IdType="pmc">PMC5234837</ArticleId><ArticleId IdType="pubmed">28085957</ArticleId></ArticleIdList></Reference><Reference><Citation>Shahin D, El-Farahaty RM, Houssen ME, et al. . Serum 25-OH vitamin D level in treatment-Na&#xef;ve systemic lupus erythematosus patients: relation to disease activity, IL-23 and IL-17. Lupus 2017;26:917&#x2013;26. 10.1177/0961203316682095</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316682095</ArticleId><ArticleId IdType="pubmed">27927883</ArticleId></ArticleIdList></Reference><Reference><Citation>Buyon JP, Petri MA, Kim MY, et al. . The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial. Ann Intern Med 2005;142:953&#x2013;62. 10.7326/0003-4819-142-12_part_1-200506210-00004</Citation><ArticleIdList><ArticleId IdType="doi">10.7326/0003-4819-142-12_part_1-200506210-00004</ArticleId><ArticleId IdType="pubmed">15968009</ArticleId></ArticleIdList></Reference><Reference><Citation>Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. . Evaluation, treatment, and prevention of vitamin D deficiency: an endocrine society clinical practice guideline. J Clin Endocrinol Metab 2011;96:1911&#x2013;30. 10.1210/jc.2011-0385</Citation><ArticleIdList><ArticleId IdType="doi">10.1210/jc.2011-0385</ArticleId><ArticleId IdType="pubmed">21646368</ArticleId></ArticleIdList></Reference><Reference><Citation>Islam MA, Khandker SS, Alam SS, et al. . Vitamin D status in patients with systemic lupus erythematosus (SLE): a systematic review and meta-analysis. Autoimmun Rev 2019;18:102392. 10.1016/j.autrev.2019.102392</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2019.102392</ArticleId><ArticleId IdType="pubmed">31520805</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang XR, Xiao JP, Zhang JJ, et al. . Decreased serum/plasma vitamin D levels in SLE patients: a meta-analysis. Curr Pharm Des 2018;24:4466&#x2013;73. 10.2174/1381612825666190111145848</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/1381612825666190111145848</ArticleId><ArticleId IdType="pubmed">30636593</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x41f;&#x43e;&#x432;&#x43e;&#x440;&#x43e;&#x437;&#x43d;&#x44e;&#x43a; &#x412;&#x412;, &#x411;&#x430;&#x43b;&#x430;&#x446;&#x44c;&#x43a;&#x430; &#x41d;&#x406;. &#x414;&#x435;&#x444;&#x456;&#x446;&#x438;&#x442; &#x412;&#x456;&#x442;&#x430;&#x43c;&#x456;&#x43d;&#x443; D &#x423; &#x41d;&#x430;&#x441;&#x435;&#x43b;&#x435;&#x43d;&#x43d;&#x44f; &#x423;&#x43a;&#x440;&#x430;&#x457;&#x43d;&#x438; &#x422;&#x430; &#x424;&#x430;&#x43a;&#x442;&#x43e;&#x440;&#x438; &#x420;&#x438;&#x437;&#x438;&#x43a;&#x443; &#x419;&#x43e;&#x433;&#x43e; &#x420;&#x43e;&#x437;&#x432;&#x438;&#x442;&#x43a;&#x443;. &#x416;&#x443;&#x440;&#x43d;&#x430;&#x43b; "&#x411;&#x456;&#x43b;&#x44c; &#x421;&#x443;&#x433;&#x43b;&#x43e;&#x431;&#x438; &#x425;&#x440;&#x435;&#x431;&#x435;&#x442; 2014;1&#x2013;2:5&#x2013;8.</Citation></Reference><Reference><Citation>Bultink IEM. Bone disease in connective tissue disease/systemic lupus erythematosus. Calcif Tissue Int 2018;102:575&#x2013;91. 10.1007/s00223-017-0322-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00223-017-0322-z</ArticleId><ArticleId IdType="pmc">PMC5904226</ArticleId><ArticleId IdType="pubmed">28900675</ArticleId></ArticleIdList></Reference><Reference><Citation>Salman-Monte TC, Torrente-Segarra V, Vega-Vidal AL, et al. . Bone mineral density and vitamin D status in systemic lupus erythematosus (SLE): a systematic review. Autoimmun Rev 2017;16:1155&#x2013;9. 10.1016/j.autrev.2017.09.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2017.09.011</ArticleId><ArticleId IdType="pubmed">28899800</ArticleId></ArticleIdList></Reference><Reference><Citation>Edens C, Robinson AB. Systemic lupus erythematosus, bone health, and osteoporosis. Curr Opin Endocrinol Diabetes Obes 2015;22:422&#x2013;31. 10.1097/MED.0000000000000197</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MED.0000000000000197</ArticleId><ArticleId IdType="pubmed">26414079</ArticleId></ArticleIdList></Reference><Reference><Citation>Carli L, Tani C, Spera V, et al. . Risk factors for osteoporosis and fragility fractures in patients with systemic lupus erythematosus. Lupus Sci Med 2016;3:e000098. 10.1136/lupus-2015-000098</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2015-000098</ArticleId><ArticleId IdType="pmc">PMC4731833</ArticleId><ArticleId IdType="pubmed">26848397</ArticleId></ArticleIdList></Reference><Reference><Citation>Schneider L, Colar da Silva AC, Werres Junior LC, et al. . Vitamin D levels and cytokine profiles in patients with systemic lupus erythematosus. Lupus 2015;24:1191&#x2013;7. 10.1177/0961203315584811</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315584811</ArticleId><ArticleId IdType="pubmed">25926056</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng R, Gonzalez A, Yue J, et al. . Efficacy and safety of vitamin D supplementation in patients with systemic lupus erythematosus: a meta-analysis of randomized controlled trials. Am J Med Sci 2019;358:104&#x2013;14. 10.1016/j.amjms.2019.04.020</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.amjms.2019.04.020</ArticleId><ArticleId IdType="pubmed">31331447</ArticleId></ArticleIdList></Reference><Reference><Citation>Mok CC, Bro ET, Ho LY, et al. . Serum 25-hydroxyvitamin D3 levels and flares of systemic lupus erythematosus: a longitudinal cohort analysis. Clin Rheumatol 2018;37:2685&#x2013;92. 10.1007/s10067-018-4204-1</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10067-018-4204-1</ArticleId><ArticleId IdType="pubmed">30014357</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M. EULAR/ACR classification criteria for SLE. Semin Arthritis Rheum 2019;49:S14&#x2013;7. 10.1016/j.semarthrit.2019.09.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2019.09.009</ArticleId><ArticleId IdType="pubmed">31779843</ArticleId></ArticleIdList></Reference><Reference><Citation>Gladman D, Ginzler E, Goldsmith C, et al. . The development and initial validation of the systemic lupus international collaborating clinics/American college of rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996;39:363&#x2013;9. 10.1002/art.1780390303</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.1780390303</ArticleId><ArticleId IdType="pubmed">8607884</ArticleId></ArticleIdList></Reference><Reference><Citation>Toloza SMA, Cole DEC, Gladman DD, et al. . Vitamin D insufficiency in a large female SLE cohort. Lupus 2010;19:13&#x2013;9. 10.1177/0961203309345775</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203309345775</ArticleId><ArticleId IdType="pubmed">19897520</ArticleId></ArticleIdList></Reference><Reference><Citation>Dutta C, Kakati S, Barman B, et al. . Vitamin D status and its relationship with systemic lupus erythematosus as a determinant and outcome of disease activity. Horm Mol Biol Clin Investig 2019;38. 10.1515/hmbci-2018-0064</Citation><ArticleIdList><ArticleId IdType="doi">10.1515/hmbci-2018-0064</ArticleId><ArticleId IdType="pubmed">30943171</ArticleId></ArticleIdList></Reference><Reference><Citation>Thudi A, Yin S, Wandstrat AE, et al. . Vitamin D levels and disease status in Texas patients with systemic lupus erythematosus. Am J Med Sci 2008;335:99&#x2013;104. 10.1097/MAJ.0b013e318134eeb6</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAJ.0b013e318134eeb6</ArticleId><ArticleId IdType="pubmed">18277116</ArticleId></ArticleIdList></Reference><Reference><Citation>Damanhouri LH. Vitamin D deficiency in Saudi patients with systemic lupus erythematosus. Saudi Med J 2009;30:1291&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">19838436</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultink IEM, Lems WF, Kostense PJ, et al. . Prevalence of and risk factors for low bone mineral density and vertebral fractures in patients with systemic lupus erythematosus. Arthritis Rheum 2005;52:2044&#x2013;50. 10.1002/art.21110</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.21110</ArticleId><ArticleId IdType="pubmed">15986345</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamza RT, Awwad KS, Ali MK, et al. . Reduced serum concentrations of 25-hydroxy vitamin D in Egyptian patients with systemic lupus erythematosus: relation to disease activity. Med Sci Monit 2011;17:CR711&#x2013;8. 10.12659/msm.882131</Citation><ArticleIdList><ArticleId IdType="doi">10.12659/msm.882131</ArticleId><ArticleId IdType="pmc">PMC3628141</ArticleId><ArticleId IdType="pubmed">22129903</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan SY, Cai HY, Wang P, et al. . Association between circulating 25-hydroxyvitamin D and systemic lupus erythematosus: a systematic review and meta-analysis. Int J Rheum Dis 2019;22:1803&#x2013;13. 10.1111/1756-185X.13676</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1756-185X.13676</ArticleId><ArticleId IdType="pubmed">31468723</ArticleId></ArticleIdList></Reference><Reference><Citation>Souto M, Coelho A, Guo C, et al. . Vitamin D insufficiency in Brazilian patients with SLE: prevalence, associated factors, and relationship with activity. Lupus 2011;20:1019&#x2013;26. 10.1177/0961203311401457</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203311401457</ArticleId><ArticleId IdType="pubmed">21646315</ArticleId></ArticleIdList></Reference><Reference><Citation>Adel Y, Elgamal M, Adel Abdelsalam S. Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic. Arch Rheumatol 2022;37:288&#x2013;99. 10.46497/ArchRheumatol.2022.8996</Citation><ArticleIdList><ArticleId IdType="doi">10.46497/ArchRheumatol.2022.8996</ArticleId><ArticleId IdType="pmc">PMC9377176</ArticleId><ArticleId IdType="pubmed">36017215</ArticleId></ArticleIdList></Reference><Reference><Citation>&#x42f;&#x43a;&#x43e;&#x432;&#x43b;&#x435;&#x432;&#x430; &#x41e;&#x41e;, &#x414;&#x43e;&#x440;&#x43e;&#x448;&#x43a;&#x435;&#x432;&#x438;&#x447; &#x406;&#x41e;, &#x41d;&#x456;&#x43a;&#x43e;&#x43b;&#x43e;&#x432;&#x430; &#x41e;&#x41c;. &#x421;&#x442;&#x440;&#x443;&#x43a;&#x442;&#x443;&#x440;&#x430; &#x440;&#x435;&#x446;&#x435;&#x43f;&#x442;&#x43e;&#x440;&#x430; &#x432;&#x456;&#x442;&#x430;&#x43c;&#x456;&#x43d;&#x443; &#x414; &#x442;&#x430; &#x439;&#x43e;&#x433;&#x43e; &#x433;&#x435;&#x43d;&#x43e;&#x43c;&#x43d;&#x456; &#x440;&#x435;&#x433;&#x443;&#x43b;&#x44f;&#x442;&#x43e;&#x440;&#x43d;&#x456; &#x444;&#x443;&#x43d;&#x43a;&#x446;&#x456;&#x457;. In &#x412;&#x456;&#x441;&#x43d;&#x438;&#x43a; &#x412;&#x456;&#x43d;&#x43d;&#x438;&#x446;&#x44c;&#x43a;&#x43e;&#x433;&#x43e; &#x43d;&#x430;&#x446;&#x456;&#x43e;&#x43d;&#x430;&#x43b;&#x44c;&#x43d;&#x43e;&#x433;&#x43e; &#x43c;&#x435;&#x434;&#x438;&#x447;&#x43d;&#x43e;&#x433;&#x43e; &#x443;&#x43d;&#x456;&#x432;&#x435;&#x440;&#x441;&#x438;&#x442;&#x435;&#x442;&#x443;. 2020: 24.</Citation></Reference><Reference><Citation>Hiraki LT, Major JM, Chen C, et al. . Exploring the genetic architecture of circulating 25-hydroxyvitamin D // genetic epidemiology. Genet Epidemiol 2013;37:92&#x2013;8. 10.1002/gepi.21694</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/gepi.21694</ArticleId><ArticleId IdType="pmc">PMC3524394</ArticleId><ArticleId IdType="pubmed">23135809</ArticleId></ArticleIdList></Reference><Reference><Citation>Nissen J, Rasmussen LB, Ravn-Haren G, et al. . Common variant sin CYP2R1 and GC genes predict vitamin D concentration sin healthy Danish children and adults. PLoS ONE 2014;9:e89907. 10.1371/journal.pone.0089907</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0089907</ArticleId><ArticleId IdType="pmc">PMC3937412</ArticleId><ArticleId IdType="pubmed">24587115</ArticleId></ArticleIdList></Reference><Reference><Citation>Zayny A, Almokhtar M, Wikvall K, et al. . Effects of glucocorticoids on vitamin D3-metabolizing 24-hydroxylase (Cyp24A1) in Saos-2 cells and primary human osteoblasts. Mol Cell Endocrinol 2019;496:110525. 10.1016/j.mce.2019.110525</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mce.2019.110525</ArticleId><ArticleId IdType="pubmed">31352041</ArticleId></ArticleIdList></Reference><Reference><Citation>Akeno N, Matsunuma A, Maeda T, et al. . Regulation of vitamin D1Alpha-hydroxylase and -24-hydroxylase expression by dexamethasone in mouse kidney. J Endocrinol 2000;164:339&#x2013;48. 10.1677/joe.0.1640339</Citation><ArticleIdList><ArticleId IdType="doi">10.1677/joe.0.1640339</ArticleId><ArticleId IdType="pubmed">10694374</ArticleId></ArticleIdList></Reference><Reference><Citation>Kurahashi I, Matsunuma A, Kawane T, et al. . Dexamethasone enhances vitamin D-24-hydroxylase expression in osteoblastic (UMR106) and renal (LLC-PK 1) cells treated with 1A, 25-dihydroxyvitamin D3. Endocrine 2002;17:109&#x2013;18. 10.1385/ENDO:17:2:109</Citation><ArticleIdList><ArticleId IdType="doi">10.1385/ENDO:17:2:109</ArticleId><ArticleId IdType="pubmed">12041912</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhawan P, Christakos S. Novel regulation of 25-hydroxyvitamin D3 24-hydroxylase (24(OH)Ase) transcription by glucocorticoids: cooperative effects of the glucocorticoid receptor, C/EBP beta, and the vitamin D receptor in 24(OH)Ase transcription. J Cell Biochem 2010;110:1314&#x2013;23. 10.1002/jcb.22645</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcb.22645</ArticleId><ArticleId IdType="pubmed">20564225</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimberg DV, Baerg RD, Gershon E, et al. . Effect of cortisone treatment on the active transport of calcium by the small intestine. J Clin Invest 1971;50:1309&#x2013;21. 10.1172/JCI106610</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI106610</ArticleId><ArticleId IdType="pmc">PMC292062</ArticleId><ArticleId IdType="pubmed">4325312</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesney RW, Mazess RB, Hamstra AJ, et al. . Reduction of Serum-1, 25-dihydroxyvitamin-D3 in children receiving glucocorticoids. Lancet 1978;2:1123&#x2013;5. 10.1016/s0140-6736(78)92277-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0140-6736(78)92277-8</ArticleId><ArticleId IdType="pubmed">82684</ArticleId></ArticleIdList></Reference><Reference><Citation>Szalai AJ, van Ginkel FW, Dalrymple SA, et al. . Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 1998;160:5294&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9605127</ArticleId></ArticleIdList></Reference><Reference><Citation>Studnicka-Benke A, Steiner G, Petera P, et al. . Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996;35:1067&#x2013;74. 10.1093/rheumatology/35.11.1067</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/35.11.1067</ArticleId><ArticleId IdType="pubmed">8948291</ArticleId></ArticleIdList></Reference><Reference><Citation>Gr&#xf6;ndal G, Gunnarsson I, R&#xf6;nnelid J, et al. . Cytokine production, serum levels and disease activity in systemic lupus erythematosus. Clin Exp Rheumatol 2000;18:565&#x2013;70.</Citation><ArticleIdList><ArticleId IdType="pubmed">11072595</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M. Inflammatory markers in systemic lupus erythematosus. J Autoimmun 2020;110:102374. 10.1016/j.jaut.2019.102374</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaut.2019.102374</ArticleId><ArticleId IdType="pubmed">31812331</ArticleId></ArticleIdList></Reference><Reference><Citation>Yao HH, Tang SM, Wang ZM, et al. . Study of bone mineral density and serum bone turnover markers in newly diagnosed systemic lupus erythematosus patients. Beijing Da Xue Xue Bao Yi Xue Ban 2018;50:998&#x2013;1003.</Citation><ArticleIdList><ArticleId IdType="pubmed">30562771</ArticleId></ArticleIdList></Reference><Reference><Citation>Amital H, Szekanecz Z, Sz&#xfc;cs G, et al. . Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Ann Rheum Dis 2010;69:1155&#x2013;7. 10.1136/ard.2009.120329</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2009.120329</ArticleId><ArticleId IdType="pubmed">20439290</ArticleId></ArticleIdList></Reference><Reference><Citation>Athanassiou L, Kostoglou-Athanassiou I, Tsakiridis P, et al. . Vitamin D levels in Greek patients with systemic lupus erythematosus. Lupus 2022;31:125&#x2013;32. 10.1177/09612033211066462</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211066462</ArticleId><ArticleId IdType="pubmed">35006029</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardona-Cardona AF, Cer&#xf3;n y Cer&#xf3;n JA. Vitamin D in Colombian patients with systemic lupus erythematosus and its correlation with disease activity. Lupus 2020;29:1297&#x2013;304. 10.1177/0961203320937783</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320937783</ArticleId><ArticleId IdType="pubmed">32623952</ArticleId></ArticleIdList></Reference><Reference><Citation>Miskovic R, Plavsic A, Raskovic S, et al. . Vitamin D status in patients with systemic lupus erythematosus in Serbia: correlation with disease activity and clinical manifestations. Open Access Maced J Med Sci 2015;3:256&#x2013;61. 10.3889/oamjms.2015.052</Citation><ArticleIdList><ArticleId IdType="doi">10.3889/oamjms.2015.052</ArticleId><ArticleId IdType="pmc">PMC4877863</ArticleId><ArticleId IdType="pubmed">27275231</ArticleId></ArticleIdList></Reference><Reference><Citation>Penna G, Adorini L. 1 Alpha,25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000;164:2405&#x2013;11. 10.4049/jimmunol.164.5.2405</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.164.5.2405</ArticleId><ArticleId IdType="pubmed">10679076</ArticleId></ArticleIdList></Reference><Reference><Citation>Pelajo CF, Lopez-Benitez JM, Miller LC. Vitamin D and autoimmune rheumatologic disorders. Autoimmun Rev 2010;9:507&#x2013;10. 10.1016/j.autrev.2010.02.011</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2010.02.011</ArticleId><ArticleId IdType="pubmed">20146942</ArticleId></ArticleIdList></Reference><Reference><Citation>Skrobot A, Demkow U, Wachowska M. Immunomodulatory role of vitamin D: a review. Adv Exp Med Biol 2018;1108:13&#x2013;23. 10.1007/5584_2018_246</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/5584_2018_246</ArticleId><ArticleId IdType="pubmed">30143987</ArticleId></ArticleIdList></Reference><Reference><Citation>Berer A, St&#xf6;ckl J, Majdic O, et al. . 1,25-dihydroxyvitamin D(3) inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000;28:575&#x2013;83. 10.1016/s0301-472x(00)00143-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/s0301-472x(00)00143-0</ArticleId><ArticleId IdType="pubmed">10812248</ArticleId></ArticleIdList></Reference><Reference><Citation>Adorini L, Penna G. Dendritic cell tolerogenicity: a key mechanism in Immunomodulation by vitamin D receptor agonists. Hum Immunol 2009;70:345&#x2013;52. 10.1016/j.humimm.2009.01.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.humimm.2009.01.016</ArticleId><ArticleId IdType="pubmed">19405173</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S, Sims GP, Chen XX, et al. . Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation. J Immunol 2007;179:1634&#x2013;47. 10.4049/jimmunol.179.3.1634</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.179.3.1634</ArticleId><ArticleId IdType="pubmed">17641030</ArticleId></ArticleIdList></Reference><Reference><Citation>Looney RJ, Anolik JH, Campbell D, et al. . B cell depletion as a novel treatment for systemic lupus erythematosus: a phase I/II dose-escalation trial of Rituximab. Arthritis Rheum 2004;50:2580&#x2013;9. 10.1002/art.20430</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/art.20430</ArticleId><ArticleId IdType="pubmed">15334472</ArticleId></ArticleIdList></Reference><Reference><Citation>Grammer AC, Lipsky PE. B cell abnormalities in systemic lupus erythematosus. Arthritis Res Ther 2003;5 Suppl 4:S22&#x2013;7. 10.1186/ar1009</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/ar1009</ArticleId><ArticleId IdType="pmc">PMC2833441</ArticleId><ArticleId IdType="pubmed">15180894</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo Q, Fan P, Luo J, et al. . Assessment of bone mineral density and bone metabolism in young male adults recently diagnosed with systemic lupus erythematosus in China. Lupus 2017;26:289&#x2013;93. 10.1177/0961203316664596</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203316664596</ArticleId><ArticleId IdType="pubmed">27522093</ArticleId></ArticleIdList></Reference><Reference><Citation>Tianle W, Yingying Z, Baojian H, et al. . The changes in bone turnover markers of female systemic lupus erythematousus patients without glucocorticoid. Lupus 2021;30:965&#x2013;71. 10.1177/09612033211000126</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/09612033211000126</ArticleId><ArticleId IdType="pubmed">33715496</ArticleId></ArticleIdList></Reference><Reference><Citation>Sarkissian A, Sivaraman V, Bout-Tabaku S, et al. . Bone turnover markers in relation to vitamin D status and disease activity in adults with systemic lupus erythematosus. Lupus 2019;28:156&#x2013;62. 10.1177/0961203318815593</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203318815593</ArticleId><ArticleId IdType="pubmed">30509154</ArticleId></ArticleIdList></Reference><Reference><Citation>Dhillon VB, Davies MC, Hall ML, et al. . Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus: a preliminary study with dual energy X Ray absorptiometry. Ann Rheum Dis 1990;49:624&#x2013;6. 10.1136/ard.49.8.624</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.49.8.624</ArticleId><ArticleId IdType="pmc">PMC1004178</ArticleId><ArticleId IdType="pubmed">2396869</ArticleId></ArticleIdList></Reference><Reference><Citation>Souto MID, Coelho A, Guo C, et al. . The prevalence of low bone mineral density in Brazilian patients with systemic lupus erythematosus and its relationship with the disease damage index and other associated factors. J Clin Densitom 2012;15:320&#x2013;7. 10.1016/j.jocd.2011.12.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jocd.2011.12.002</ArticleId><ArticleId IdType="pubmed">22321657</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang XL, Griffith JF, Qin L, et al. . SLE disease per se contributes to deterioration in bone mineral density, microstructure and bone strength. Lupus 2013;22:1162&#x2013;8. 10.1177/0961203313498802</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313498802</ArticleId><ArticleId IdType="pubmed">23884986</ArticleId></ArticleIdList></Reference><Reference><Citation>Lacativa PGS, Farias MLF de. Osteoporosis and inflammation. Arq Bras Endocrinol Metab 2010;54:123&#x2013;32. 10.1590/S0004-27302010000200007</Citation><ArticleIdList><ArticleId IdType="doi">10.1590/S0004-27302010000200007</ArticleId><ArticleId IdType="pubmed">20485900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bultink IEM, Vis M, van der Horst-Bruinsma IE, et al. . Inflammatory rheumatic disorders and bone. Curr Rheumatol Rep 2012;14:224&#x2013;30. 10.1007/s11926-012-0252-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-012-0252-8</ArticleId><ArticleId IdType="pmc">PMC3338911</ArticleId><ArticleId IdType="pubmed">22477520</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>